Drug Database
Back to search

France· FR:61065137

MYOZYME 50 mg, poudre pour solution à diluer pour perfusion

A alglucosidase alfa product containing alglucosidase alfa, registered in France by SANOFI (PAYS-BAS). The same ATC class is registered in 14 of our 19 countries.

ATC A16AB07

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedMYOZYME 50 mg, poudre pour solution à…ATCA16AB07REGISTER NO.FR:61065137PACKS LISTED4CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about alglucosidase alfaAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Alglucosidase alfa is registered in 14 of 19 countries.

Countries holding a registration under ATC A16AB07 (alglucosidase alfa), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose
Search alglucosidase alfa products by name

Alglucosidase alfa · ATC A16AB07

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of alglucosidase alfa costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Alglucosidase alfa · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1240.40
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ALGLUCOSIDASE ALFA
Manufacturer
SANOFI (PAYS-BAS)
Country
France (FR)
ATC code
A16AB07
ATC class
Alglucosidase alfa
Defined daily dose
0.1 g, P
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 4

  • cip13
    3400930247006
    1 flacon(s) en verre de 20 ml
  • cip13
    3400930247013
    10 flacon(s) en verre de 20 ml
  • cip13
    3400956957514
    1 flacon(s) en verre ( abrogée le 09/01/2023)
  • cip13
    3400956957682
    10 flacon(s) en verre ( abrogée le 09/01/2023)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Alglucosidase alfa in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All alglucosidase alfa products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Myozyme
  • Liechtenstein · Myozyme
  • Norway · Myozyme

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/38eb4581-00f8-45f7-8a31-33f600dd4412
GET /v1/drugs/38eb4581-00f8-45f7-8a31-33f600dd4412?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61065137",
  "date_amm": "2006-03-29",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/06/333",
  "substance": "ALGLUCOSIDASE ALFA",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre pour solution à diluer pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about alglucosidase alfa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console